The Clinical Research Organization industry has reached a new level of development in clinical trials. There are now more than twelve hundred CROs with the greatest number existing in Europe, followed by North America and Asia. With research and development costs at an all time high, product approvals are trending downward and large scale drug development is becoming flat in the pharmaceutical industry. However, the growth rate in the CRO industry has been substantially trending upward as is the case with Limdato www.limdato.com .